-
Corvus Pharmaceuticals (NASDAQ:CRVS) Receives "Buy" Rating from HC Wainwright
ソース: Buzz FX / 14 1 2025 08:16:16 America/New_York
Corvus Pharmaceuticals (NASDAQ:CRVS) Receives "Buy" Rating from HC Wainwright Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Corvus Pharmaceuticals ( NASDAQ:CRVS - Get Free Report ) 's stock had its "buy" rating rest
Read more...